John Farah
Director/Board Member presso AEOLUS PHARMACEUTICALS, INC.
Patrimonio netto: 1 339 $ in data 31/03/2024
Posizioni attive di John Farah
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AEOLUS PHARMACEUTICALS, INC. | Director/Board Member | 24/10/2005 | - |
| Independent Dir/Board Member | 23/05/2011 | - | |
| POND TECHNOLOGIES HOLDINGS INC. | Director/Board Member | 14/07/2021 | - |
Storia della carriera di John Farah
Precedenti posizioni note di John Farah
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | 01/10/1992 | - |
| REBUS HOLDINGS, INC. | Director/Board Member | 01/02/2008 | 17/08/2010 |
| Independent Dir/Board Member | 01/02/2008 | 17/08/2010 | |
Melior Discovery, Inc.
 Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | Director/Board Member | 11/01/2013 | 16/01/2013 |
| Independent Dir/Board Member | 11/01/2013 | 16/01/2013 | |
| Corporate Officer/Principal | 16/01/2013 | - | |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Chief Tech/Sci/R&D Officer | - | - |
Formazione di John Farah
| New College of California | Undergraduate Degree |
| University of Maryland | Undergraduate Degree |
| Uniformed Services University of the Health Sciences | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 9 |
| Canada | 2 |
Posizioni
| Director/Board Member | 4 |
| Independent Dir/Board Member | 3 |
| Undergraduate Degree | 2 |
Settori
| Health Technology | 5 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| REBUS HOLDINGS, INC. | Health Technology |
| AEOLUS PHARMACEUTICALS, INC. | Health Technology |
| POND TECHNOLOGIES HOLDINGS INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Melior Discovery, Inc.
Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | Commercial Services |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
- Borsa valori
- Insiders
- John Farah
- Esperienza
